Literature DB >> 12750254

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.

Masayuki Shiseki1, Makoto Nagashima, Remy M Pedeux, Mariko Kitahama-Shiseki, Koh Miura, Shu Okamura, Hitoshi Onogi, Yuichiro Higashimoto, Ettore Appella, Jun Yokota, Curtis C Harris.   

Abstract

We identified and characterized two new ING family genes, p29ING4 and p28ING5,coding for two proteins of 249 and 240 amino acids, respectively. Both p29ING4 and p28ING5 proteins have a plant homeodomain finger motif also found in other ING proteins, and which is common in proteins involved in chromatin remodeling. p29ING4 or p28ING5 overexpression resulted in a diminished colony-forming efficiency, a decreased cell population in S phase, and the induction of apoptosis in a p53-dependent manner. Both p29ING4 and p28ING5 activate the p21/waf1 promoter, and induce p21/WAF1 expression. p29ING4 and p28ING5 enhance p53 acetylation at Lys-382 residues, and physically interact with p300, a member of histone acetyl transferase complexes, and p53 in vivo. These results indicate that p29ING4 and p28ING5 may be significant modulators of p53 function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750254

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  120 in total

1.  Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation.

Authors:  Nikita Avvakumov; Marie-Eve Lalonde; Nehmé Saksouk; Eric Paquet; Karen C Glass; Anne-Julie Landry; Yannick Doyon; Christelle Cayrou; Geneviève A Robitaille; Darren E Richard; Xiang-Jiao Yang; Tatiana G Kutateladze; Jacques Côté
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

2.  Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity.

Authors:  Andrew H Coles; Hugh Gannon; Anna Cerny; Evelyn Kurt-Jones; Stephen N Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 3.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

4.  A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis.

Authors:  Suwon Kim; Alana L Welm; J Michael Bishop
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

5.  ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Authors:  Remy Pedeux; Sagar Sengupta; Jiang Cheng Shen; Oleg N Demidov; Shin'ichi Saito; Hitoshi Onogi; Kensuke Kumamoto; Stephen Wincovitch; Susan H Garfield; Mary McMenamin; Makoto Nagashima; Steven R Grossman; Ettore Appella; Curtis C Harris
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

6.  A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis.

Authors:  Motoko Unoki; Kensuke Kumamoto; Ana I Robles; Jiang Cheng Shen; Zhi-Ming Zheng; Curtis C Harris
Journal:  FEBS Lett       Date:  2008-10-23       Impact factor: 4.124

7.  Cytoplasmic expression of p33(ING1b) is correlated with tumorigenesis and progression of human esophageal squamous cell carcinoma.

Authors:  Zhen-Long Zhu; Bao-Yong Yan; Yu Zhang; Yan-Hong Yang; Zheng-Min Wang; Hong-Zhen Zhang; Ming-Wei Wang; Xiang-Hong Zhang; Xiao-Feng Sun
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

8.  Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.

Authors:  Julieta M Ceruti; María F Ogara; Camino Menéndez; Ignacio Palmero; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2013-03-04       Impact factor: 3.396

Review 9.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

Review 10.  Structural insight into histone recognition by the ING PHD fingers.

Authors:  Karen S Champagne; Tatiana G Kutateladze
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.